David Baxley Spetzler - 03 Mar 2025 Form 4 Insider Report for Caris Life Sciences, Inc.

Reporting relationship: President
Issuer ticker: CAI on Nasdaq
Reported as of: 03 Mar 2025
Net transaction value: -$13,794,277
SEC form: 4
Accepted by SEC: 23 Jun 2025, 18:41:24 UTC
Next SEC filing: 17 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ J. Russel Denton, Attorney-in-Fact

Key filing fact

David Baxley Spetzler filed Form 4 for Caris Life Sciences, Inc. on 23 Jun 2025.

Key facts

This page summarizes David Baxley Spetzler's Form 4 filing for Caris Life Sciences, Inc..
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 23 Jun 2025, 18:41.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: -$13,794,277.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002071953 Primary reporting owner

Spetzler David Baxley

Relationship: President
Address: C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING
Signature: /s/ J. Russel Denton, Attorney-in-Fact
Signature date: 23 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CAI transaction

Common Stock

Disposed to Issuer

Transaction value: $13,029,467
Shares: -700,509
Change %: -67%
Price: $18.60
Shares after: 351,240
Date: 03 Mar 2025
Ownership: Direct
Footnotes: F1, F2

CAI transaction

Common Stock

Award

Transaction value: $0
Shares: +132,428
Change %: +38%
Price: $0.000000
Shares after: 483,668
Date: 18 Jun 2025
Ownership: Direct
Footnotes: F3

CAI transaction

Common Stock

Options Exercise

Transaction value: $183,000
Shares: +75,000
Change %: +16%
Price: $2.44
Shares after: 558,668
Date: 20 Jun 2025
Ownership: Direct

CAI transaction

Common Stock

Tax liability

Transaction value: $947,810
Shares: -34,782
Change %: -6.2%
Price: $27.25
Shares after: 523,886
Date: 20 Jun 2025
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CAI transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +750,000
Change %
Price: $0.000000
Shares after: 750,000
Date: 03 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 750,000
Exercise price: $18.60
Footnotes: F4

CAI transaction Derivative

Stock Option

Options Exercise

Transaction value: $0
Shares: -75,000
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 20 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 75,000
Exercise price: $2.44
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents shares of Common Stock surrendered to the Issuer as repayment for an outstanding promissory note.

Footnote F2

Includes 151,750 shares of Common Stock underlying restricted stock units which vest in accordance with the applicable grant agreements, which securities were previously reported on the Reporting Person's Form 3. All the securities reported in this Form 4 reflect a one-for-four reverse stock split effected as of June 1, 2025.

Footnote F3

Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.

Footnote F4

The stock option vested 60% at grant and will vest 20% on August 11, 2025 and 20% on August 11, 2026. These securities were previously reported on the Reporting Person's Form 3.

Footnote F5

The stock option is fully vested and exercisable.